A multi-specific, multi-affinity antibody platform neutralizes sarbecoviruses and confers protection against SARS-CoV-2 in vivo - Science

A multi-specific, multi-affinity antibody platform neutralizes sarbecoviruses and confers protection against SARS-CoV-2 in vivo  ScienceNucleocapsid-specific T cell responses associate with control of SARS-CoV-2 in the upper airways before seroconversion  Nature.comDrugs that Covid & flu viruses can’t resist found  Indiatimes.comNew Indian drug candidates to fight existing as well as emerging Covid strains  Deccan HeraldCoronavirus spike protein-